retatrutide cancer Glucagon-like peptide-1 medicines and Retatrutide Peptide and Tumor Growth:
Description
Microdosing GLP1
Beyond these well-known effects, an interesting aspect of this drug is its antiatherogenic activity, which should be further explored in clinical practice
Learn when to stop GLP-1s before pregnancy, what happens if you conceive on one, and whether they're safe while breastfeeding.
Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R)
Todd Sohn, Strategas ETF & Technical Strategist, also joins the conversation.
